Acorda Therapeutics
ACOR
$0.66
Share price
0.00%
Change (1 day)
40.64%
Change (1 year)
Categories
Acorda Therapeutics (ACOR) - Cash on Hand
Cash on Hand as of September 2023 : $32.46 M
According to Acorda Therapeutics
's latest financial reports the company has $32.46 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Acorda Therapeutics - Cash on Hand chart (from 2003 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $37.53 M | -17.75% |
| 2021-12-31 | $45.63 M | -36.06% |
| 2020-12-31 | $71.36 M | -43.29% |
| 2019-12-31 | $0.12 B | -71.76% |
| 2018-12-31 | $0.44 B | 45.1% |
| 2017-12-31 | $0.30 B | 93.69% |
| 2016-12-31 | $0.15 B | -55.13% |
| 2015-12-31 | $0.35 B | 14.85% |
| 2014-12-31 | $0.30 B | 12.3% |
| 2013-12-31 | $0.27 B | 17.15% |
| 2012-12-31 | $0.23 B | -20.98% |
| 2011-12-31 | $0.29 B | 23.28% |
| 2010-12-31 | $0.24 B | -11.78% |
| 2009-12-31 | $0.27 B | 10.58% |
| 2008-12-31 | $0.24 B | 158.67% |
| 2007-12-31 | $95.12 M | 76.95% |
| 2006-12-31 | $53.75 M | 290.6% |
| 2005-12-31 | $13.76 M | -34.85% |
| 2004-12-31 | $21.12 M | -48.74% |
| 2003-12-31 | $41.21 M | |
| 2003-06-30 | $60.56 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Sarepta Therapeutics
SRPT | $1.67 B | 5,062.78% | 🇺🇸 USA |
 Repligen
RGEN | $0.75 B | 2,214.04% | 🇺🇸 USA |
 Affimed
AFMD | $0.10 B | 217.19% | 🇩🇪 Germany |
 BioMarin Pharmaceutical BMRN | $1.07 B | 3,207.29% | 🇺🇸 USA |